Post-translational Regulation of Neuronal Nitric Oxide Synthase: Implications for Sympathoexcitatory States

Overview

Journal Expert Opin Ther Targets

Publisher Informa Healthcare

Specialty Pharmacology

Date 2016 Nov 26

PMID 27885874

Citations 14

Authors

Neeru M Sharma

Kaushik P Patel

Affiliations

Soon will be listed here.

Abstract

Nitric oxide (NO) synthesized via neuronal nitric oxide synthase (nNOS) plays a significant role in regulation/modulation of autonomic control of circulation. Various pathological states are associated with diminished nNOS expression and blunted autonomic effects of NO in the central nervous system (CNS) including heart failure, hypertension, diabetes mellitus, chronic renal failure etc. Therefore, elucidation of the molecular mechanism/s involved in dysregulation of nNOS is essential to understand the pathogenesis of increased sympathoexcitation in these diseased states. Areas covered: nNOS is a highly regulated enzyme, being regulated at transcriptional and posttranslational levels via protein-protein interactions and modifications viz. phosphorylation, ubiquitination, and sumoylation. The enzyme activity of nNOS also depends on the optimal concentration of substrate, cofactors and association with regulatory proteins. This review focuses on the posttranslational regulation of nNOS in the context of normal and diseased states within the CNS. Expert opinion: Gaining insight into the mechanism/s involved in the regulation of nNOS would provide novel strategies for manipulating nNOS directed therapeutic modalities in the future, including catalytically active dimer stabilization and protein-protein interactions with intracellular protein effectors. Ultimately, this is expected to provide tools to improve autonomic dysregulation in various diseases such as heart failure, hypertension, and diabetes.

Citing Articles

Endothelial dysfunction: molecular mechanisms and clinical implications.

Wang X, He B MedComm (2020). 2024; 5(8):e651.

PMID: 39040847 PMC: 11261813. DOI: 10.1002/mco2.651.

Effects of Akt Activator SC79 on Human M0 Macrophage Phagocytosis and Cytokine Production.

Lee R, Adappa N, Palmer J Cells. 2024; 13(11.

PMID: 38891035 PMC: 11171788. DOI: 10.3390/cells13110902.

Acetic Acid: An Underestimated Metabolite in Ethanol-Induced Changes in Regulating Cardiovascular Function.

Chapp A, Shan Z, Chen Q Antioxidants (Basel). 2024; 13(2).

PMID: 38397737 PMC: 10886048. DOI: 10.3390/antiox13020139.

Inhaled nitric oxide: can it serve as a savior for COVID-19 and related respiratory and cardiovascular diseases?.

Zhao Y, Li C, Zhang S, Cheng J, Liu Y, Han X Front Microbiol. 2023; 14:1277552.

PMID: 37849924 PMC: 10577426. DOI: 10.3389/fmicb.2023.1277552.

Nrf2 and autonomic dysregulation in chronic heart failure and hypertension.

Wafi A Front Physiol. 2023; 14:1206527.

PMID: 37719456 PMC: 10500196. DOI: 10.3389/fphys.2023.1206527.

References

Chapa D, Akintade B, Son H, Woltz P, Hunt D, Friedmann E . Pathophysiological relationships between heart failure and depression and anxiety. Crit Care Nurse. 2014; 34(2):14-24. DOI: 10.4037/ccn2014938. View

Ferguson D, Berg W, Sanders J . Clinical and hemodynamic correlates of sympathetic nerve activity in normal humans and patients with heart failure: evidence from direct microneurographic recordings. J Am Coll Cardiol. 1990; 16(5):1125-34. DOI: 10.1016/0735-1097(90)90544-y. View

Boissel J, Schwarz P, Forstermann U . Neuronal-type NO synthase: transcript diversity and expressional regulation. Nitric Oxide. 1999; 2(5):337-49. DOI: 10.1006/niox.1998.0189. View

Schuman E, Madison D . Nitric oxide and synaptic function. Annu Rev Neurosci. 1994; 17:153-83. DOI: 10.1146/annurev.ne.17.030194.001101. View

Okada D . Tetrahydrobiopterin-dependent stabilization of neuronal nitric oxide synthase dimer reduces susceptibility to phosphorylation by protein kinase C in vitro. FEBS Lett. 1998; 434(3):261-4. DOI: 10.1016/s0014-5793(98)00993-4. View

Wang S, Lin K, Chien S, Huang L, Hsu C, Tain Y . RNA silencing targeting PIN (protein inhibitor of neuronal nitric oxide synthase) attenuates the development of hypertension in young spontaneously hypertensive rats. J Am Soc Hypertens. 2013; 8(1):5-13. DOI: 10.1016/j.jash.2013.07.010. View

Cimarosti H, Lindberg C, Bomholt S, Ronn L, Henley J . Increased protein SUMOylation following focal cerebral ischemia. Neuropharmacology. 2007; 54(2):280-9. DOI: 10.1016/j.neuropharm.2007.09.010. View

Sharma N, Llewellyn T, Zheng H, Patel K . Angiotensin II-mediated posttranslational modification of nNOS in the PVN of rats with CHF: role for PIN. Am J Physiol Heart Circ Physiol. 2013; 305(6):H843-55. PMC: 3761348. DOI: 10.1152/ajpheart.00170.2013. View

Vasan R . Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation. 2006; 113(19):2335-62. DOI: 10.1161/CIRCULATIONAHA.104.482570. View

10.

Pratt W, Toft D . Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp Biol Med (Maywood). 2003; 228(2):111-33. DOI: 10.1177/153537020322800201. View

11.

Christopherson K, Hillier B, Lim W, Bredt D . PSD-95 assembles a ternary complex with the N-methyl-D-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain. J Biol Chem. 1999; 274(39):27467-73. DOI: 10.1074/jbc.274.39.27467. View

12.

Song T, Sugimoto K, Ihara H, Mizutani A, Hatano N, Kume K . p90 RSK-1 associates with and inhibits neuronal nitric oxide synthase. Biochem J. 2006; 401(2):391-8. PMC: 1820814. DOI: 10.1042/BJ20060580. View

13.

Nakane M, Mitchell J, Forstermann U, Murad F . Phosphorylation by calcium calmodulin-dependent protein kinase II and protein kinase C modulates the activity of nitric oxide synthase. Biochem Biophys Res Commun. 1991; 180(3):1396-402. DOI: 10.1016/s0006-291x(05)81351-8. View

14.

Packer M . Neurohormonal interactions and adaptations in congestive heart failure. Circulation. 1988; 77(4):721-30. DOI: 10.1161/01.cir.77.4.721. View

15.

Bredt D, Glatt C, Hwang P, Fotuhi M, Dawson T, Snyder S . Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase. Neuron. 1991; 7(4):615-24. DOI: 10.1016/0896-6273(91)90374-9. View

16.

Gillardon F, Krep H, Brinker G, Lenz C, Bottiger B, Hossmann K . Induction of protein inhibitor of neuronal nitric oxide synthase/cytoplasmic dynein light chain following cerebral ischemia. Neuroscience. 1998; 84(1):81-8. DOI: 10.1016/s0306-4522(97)00479-x. View

17.

Guix F, Uribesalgo I, Coma M, Munoz F . The physiology and pathophysiology of nitric oxide in the brain. Prog Neurobiol. 2005; 76(2):126-52. DOI: 10.1016/j.pneurobio.2005.06.001. View

18.

Swanson L, Sawchenko P . Hypothalamic integration: organization of the paraventricular and supraoptic nuclei. Annu Rev Neurosci. 1983; 6:269-324. DOI: 10.1146/annurev.ne.06.030183.001413. View

19.

Tan D, Meng S, Manning Jr R . Role of neuronal nitric oxide synthase in Dahl salt-sensitive hypertension. Hypertension. 1999; 33(1 Pt 2):456-61. DOI: 10.1161/01.hyp.33.1.456. View

20.

Luo C, Zhu D . Research progress on neurobiology of neuronal nitric oxide synthase. Neurosci Bull. 2011; 27(1):23-35. PMC: 5560277. DOI: 10.1007/s12264-011-1038-0. View